COGND
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
🇦🇺 ASX
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Performance graph isn't available yet for this share
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in COGND
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in COGND
N/A
COGND investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in COGND also invest in...
Want more shares? Try these...
Cochlear Ltd. engages in the provision of implantable hearing solutions. The company is headquartered in Sydney, New South Wales and currently employs 4,500 full-time employees. The firm designs and offers products and accessories for adults or children. The firm operates through three segments: Cochlear implants, Services and Acoustics. The Company’s Cochlear implants segment offers Cochlear implant systems, including Cochlear Nucleus Profile Plus with Slim Modiolar Electrode (CI632). Its Services segment offers sound processor upgrades, accessories and other, including Cochlear Nucleus 7 Sound Processor and Cochlear Nucleus Kanso 2 Sound Processor. Its Acoustics segment offers Bone Conduction systems and Sound processor upgrades, including Cochlear Osia 2 System and Cochlear Baha 6 Max Sound Processor. Its products and accessories include Cochlear Nucleus System, Cochlear Baha System and Cochlear Baha Start. The firm operates in America; Europe, the Middle East and Africa (EMEA), and Asia Pacific.
📊 Share price
$247.39 AUD
NULL HEALTH
